Timber Pharmaceuticals, Inc.
(NYSE Amex Equities : TMBR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. -2.37%52.770.9%$1853.04m
JNJJohnson & Johnson -0.22%164.890.7%$1003.46m
ABBVAbbVie, Inc. -0.76%132.021.9%$895.74m
MRKMerck & Co., Inc. -0.97%79.970.7%$871.92m
BMYBristol-Myers Squibb Co. -1.58%63.561.0%$666.28m
LLYEli Lilly & Co. 0.04%243.221.1%$619.62m
AZNAstraZeneca Plc -1.78%59.101.0%$237.85m
NVSNovartis AG -1.33%87.020.2%$191.45m
GSKGlaxoSmithKline Plc 0.47%45.090.2%$171.10m
NVONovo Nordisk A/S -0.12%95.350.1%$147.08m
VTRSViatris, Inc. -0.75%14.530.0%$136.80m
RGENRepligen Corp. -2.47%183.816.7%$98.97m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. -5.09%110.100.0%$73.74m
IMMXImmix Biopharma, Inc. -16.79%4.510.0%$71.11m
SNYSanofi -1.63%51.240.2%$65.54m

Company Profile

Timber Pharmaceuticals, Inc. operates as a biopharmaceutical company, which focuses on the development and commercialization of treatments for orphan dermatologic diseases. Its initial focus on developing non-systemic treatments for rare dermatologic diseases, including congenital ichthyosis, tuberous sclerosis complex, and localized scleroderma. The company was founded in 2019 and is headquartered in Basking Ridge, NJ.